Results indicated that miR-132-5p attenuated altered expression due to ketamine administration, restoring levels of BDNF, MeCP2 and TGF-b1 in the PFC, and improving depression like behaviours (Ma et al. 2022). This evidence concerns the gene TGFB1 and depressive symptom measurement.